Uzun Dönem COVID-19 Hastalarında ABO Kan Grubu Dağılımı ile Klinik Özellikler Arasındaki İlişkinin Değerlendirilmesi: Retrospektif Bir Çalışma

Yıl 2023, Cilt: 45 Sayı: 2, 290 - 300, 15.03.2023

Yaşar Bildirici , Anıl Uçan , Şebnem Eker Güvenç , Uğur Bilge

Öz

Giriş ve Amaçlar: Bu çalışma, COVID-19 İzlem Merkezine başvuran Uzun Süreli COVID hastalarında kan grupları arasındaki ilişkilerin araştırılmasını amaçlamaktadır. COVID-19 sonrası yeni komorbiditeler de değerlendirilmiştir.
Yöntemler: Bu çalışma, 13 Aralık 2020 ile 01 Kasım 2021 tarihleri arasında COVID-19 İzlem Merkezi'ne başvuran hastalar ile retrospektif olarak tasarlandı. Çalışmanın örneklemini, kan gruplarına göre 4 gruba ayrılan 502 hasta oluşturdu. Hastalar kan grubu değişkenine göre COVID-19 sonrası semptomlarına ve bulgularımıza göre analiz edildi. Hastalarımıza yeni tanı konulan komorbid hastalıkları soruldu ve hastaların ilaç öyküsü araştırıldı.
Bulgular: Toplam 502 COVID-19 hastası retrospektif olarak incelendi ve yaş ortalaması 55,5(±13,2) idi. Hastalar ağırlıklı olarak kadındı (263/502) [%52.4]. Hastaların %76,9'unda uzun süreli COVID-19 semptomları görülürken, en sık aşırı yorgunluk (%46,2) ve devam eden nefes darlığı (%32,9) görüldü. Uzun süreli COVID semptomları değerlendirildiğinde, AB ve O'ya kıyasla A ve B kan grupları ile ilişkili tek semptom kalp çarpıntısıydı (p=0,048). Hastaların kan grupları ile hastalığın semptomları ve seyri arasında anlamlı bir ilişki bulunmadı. Ayrıca devam eden semptomlarda ve C-Reaktif Protein ve Lenfosit gibi inflamatuar parametrelerde anlamlı fark yoktu.
Sonuç: Bu çalışma, kan grupları ile uzun süreli COVID-19 hastalarının klinik özellikleri arasında fark olmadığını göstermiştir.

Anahtar Kelimeler

COVID-19 Takip Merkezi, Kan Grupları, Belirtiler

Evaluation of the Relationship Between ABO Blood Group Distribution and Clinical Features in Long-Term COVID-19 Patients: A retrospective study

Öz

Background and Aims: This study aims to investigate the associations of blood groups on Long-Term COVID patients who applied to the COVID-19 Follow-up Center. New comorbidities after COVID-19 were also evaluated.
Methods: This study was designed retrospectively with patients who were admitted COVID-19 Follow-up Centre between 13th December 2020 and 01st November 2021. The study sample consisted of 502 patients divided into four groups according to their blood types. Patients were analyzed according to their symptoms and our findings after COVID-19 by blood group variable. Newly diagnosed co-morbidities were asked to our patients and the drug history of the patients was investigated
Results: A total of 502 COVID-19 patients were retrospectively analyzed and the mean age was 55.5(±13.2) years. Patients were predominantly female (263/502) [52.4%]. While long-term COVID-19 symptoms were observed in 76.9% of the patients, extreme fatigue (46.2%) and ongoing shortness of breath (32.9%) were observed most frequently. When the long-term COVID symptoms were evaluated, heart palpitation was the only symptom related to blood groups A and B compared to AB and O (p=0.048). No significant relationship was found between the blood groups of the patients and the symptoms and course of the disease. In addition, there was no significant difference in the ongoing symptoms and inflammatory parameters like C-Reactive Protein and Lymphocyte.
Conclusion: This study demonstrated that there was no difference between blood types and long-term COVID-19 patients' clinical features.

Anahtar Kelimeler

COVID-19 Takip Merkezi, Kan Grupları, Belirtiler

Kaynakça

• 1. Nejadghaderi SA, Saghazadeh A, Rezaei N. Health Care Policies and COVID-19 Prevalence: Is There Any Association? 2022 Jan 1 [cited 2022 Aug 11];52(1):9–22. Available from: https://pubmed.ncbi.nlm.nih.gov/33686893/
• 2. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data [Internet]. [cited 2021 April 22]. Available from: https://covid19.who.int/
• 3. Berger SA, Young NA, Edberg SC. Relationship between infectious diseases and human blood type. 1989 Aug [cited 2022 Feb 22];8(8):681–9. Available from: https://link.springer.com/article/10.1007/BF01963752
• 4. Liu Y, Häussinger L, Steinacker JM, Dinse-Lambracht A. Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution. 2021 [cited 2022 February 22];149. Available from: https://pubmed.ncbi.nlm.nih.gov/33407977/
• 5. Cheng Y, Cheng G, Chui CH, Lau FY, Chan PKS, Ng MHL, et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA [Internet]. 2005 Mar 23 [cited 2021 Dec 13];293(12):1450–1. Available from: https://pubmed.ncbi.nlm.nih.gov/15784866/
• 6. Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility. Clin Infect Dis [Internet]. 2021 Jul 15 [cited 2021 Dec 13];73(2):328–31. Available from: https://pubmed.ncbi.nlm.nih.gov/32750119/
• 7. Zietz M, Zucker J, Tatonetti NP. Associations between blood type and COVID-19 infection, intubation, and death. Nat Commun [Internet]. 2020 December 1 [cited 2022 February 22];11(1). Available from: https://pubmed.ncbi.nlm.nih.gov/33188185/
• 8. Shokri P, Golmohammadi S, Noori M, Nejadghaderi SA, Carson-Chahhoud K, Safiri S. The relationship between blood groups and risk of infection with SARS-CoV-2 or development of severe outcomes: A review. Rev Med Virol [Internet]. 2022 January 1 [cited 2022 August 11];32(1):e2247. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/rmv.2247
• 9. Gérard C, Maggipinto G, Minon JM. COVID-19 and ABO blood group: another viewpoint. Br J Haematol [Internet]. 2020 Jul 1 [cited 2022 Aug 11];190(2):e93–4. Available from: https://pubmed.ncbi.nlm.nih.gov/32453863/
• 10. Liu N, Zhang T, Ma L, Zhang H, Wang H, Wei W, et al. The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis. 2021 July 1 [cited 2022 August 11];48:100785. Available from: https://pubmed.ncbi.nlm.nih.gov/33309392/
• 11. Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. Long-term consequences of COVID-19: research needs [Internet]. October 1, 2020. Available from: /pmc/articles/PMC7462626/
• 12. Balachandar V, Mahalaxmi I, Subramaniam M, Kaavya J, Senthil Kumar N, Laldinmawii G, et al. Follow-up studies in COVID-19 recovered patients - is it mandatory? [Internet]. August 10, 2020 p. 139021. Available from: https://pubmed.ncbi.nlm.nih.gov/32360909/
• 13. Davison GM, Hendrickse HL, Matsha TE. Do Blood Group Antigens and the Red Cell Membrane Influence Human Immunodeficiency Virus Infection? Cells [Internet]. 2020 March 31 [cited 2022 February 24];9(4). Available from: https://pubmed.ncbi.nlm.nih.gov/32244465/
• 14. Tyrrell DAJ, Sparrow P, Beare AS. Relation between Blood Groups and Resistance to Infection with Influenza and some Picornaviruses. Nat 1968 2205169 [Internet]. 1968 [cited 2022 Feb 24];220(5169):819–20. Available from: https://www.nature.com/articles/220819a0
• 15. Hashan MR, Ghozy S, El-Qushayri AE, Pial RH, Hossain MA, Al Kibria GM. Association of dengue disease severity and blood group: A systematic review and meta-analysis. 2021 January 1 [cited 2022 September 2];31(1):1–9. Available from: https://pubmed.ncbi.nlm.nih.gov/32776660/
• 16. Noori M, Shokri P, Nejadghaderi SA, Golmohammadi S, Carson-Chahhoud K, Bragazzi NL, et al. ABO blood groups and risk of human immunodeficiency virus infection: A systematic review and meta-analysis. 2022 May 1 [cited 2022 September 2];32(3):e2298. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/rmv.2298
• 17. Rios M, Bianco C. The role of blood group antigens in infectious diseases. 2000 Apr 1 [cited 2022 Feb 24];37(2):177–85. Available from: https://pubmed.ncbi.nlm.nih.gov/10791886/
• 18. Ray JG, Schull MJ, Vermeulen MJ, Park AL. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study. Ann Intern Med [Internet]. 2021 Mar 1 [cited 2022 Feb 24];174(3):308–15. Available from: https://pubmed.ncbi.nlm.nih.gov/33226859/
• 19. Pourali F, Afshari M, Alizadeh-Navaei R, Javidnia J, Moosazadeh M, Hessami A. Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis. New microbes new Infect [Internet]. 2020 September 1 [cited 2022 September 2];37. Available from: https://pubmed.ncbi.nlm.nih.gov/32837730/
• 20. Mendy A, Keller JL, Apewokin S, Morrow AL. Is Blood Type Associated with COVID-19 Severity? medRxiv [Internet]. 2020 August 14 [cited 2022 February 24];2020.08.11.20172676. Available from: https://www.medrxiv.org/content/10.1101/2020.08.11.20172676v1
• 21. Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia [Internet]. 2022 [cited 2022 May 9];65(6):949–54. Available from: https://pubmed.ncbi.nlm.nih.gov/35292829/
• 22. Noori M, Nejadghaderi SA, Sullman MJM, Carson-Chahhoud K, Ardalan M, Kolahi AA, et al. A Review on the Possible Pathophysiology of Potassium Abnormalities in COVID-19. Iran J Kidney Dis. 2021 November 1;15(6):397–407.
• 23. Dixit NM, Churchill A, Nsair A, Hsu JJ. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? 2021 May 1 [cited 2022 May 9];5:100025. Available from: https://pubmed.ncbi.nlm.nih.gov/34192289/
• 24. Akpek M. Does COVID-19 Cause Hypertension? Angiology [Internet]. 2022 August 1 [cited 2023 January 27];73(7):682. Available from: /pmc/articles/PMC9260192/
• 25. Wu Y, Feng Z, Li P, Yu Q. Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19. 2020 October 1 [cited 2021 December 13];509. Available from: https://pubmed.ncbi.nlm.nih.gov/32562665/
• 26. Cirulli ET, Schiabor KM, 1 B, Riffle S, Bolze A, Neveux I, et al. Long-term COVID-19 symptoms in a large unselected population. medRxiv [Internet]. 2020 December 1 [cited 2023 January 27];2020.10.07.20208702. Available from: https://www.medrxiv.org/content/10.1101/2020.10.07.20208702v3
• 27. Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: A literature review. Rev Med Virol [Internet]. 2021 January 1 [cited 2022 September 2];31(1). Available from: /pmc/articles/PMC7855377/
• 28. Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, et al. Biomarkers and outcomes of COVID-19 hospitalizations: systematic review and meta-analysis. 2021 Jun 1 [cited 2022 Sep 2];26(3):107–8. Available from: https://ebm.bmj.com/content/26/3/107
• 29. Kiss S, Gede N, Hegyi PJ, Németh D, Földi M, Dembrovszky F, et al. Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19: a systematic review and meta-analysis. Med Microbiol Immunol [Internet]. 2021 Feb 1 [cited 2022 Sep 2];210(1):33. Available from: /pmc/articles/PMC7679241/
• 30. Minh LHN, Abozaid AAF, Ha NX, Le Quang L, Gad AG, Tiwari R, et al. Clinical and laboratory factors associated with coronavirus disease 2019 (Covid‐19): A systematic review and meta‐analysis. Rev Med Virol [Internet]. 2021 November 1 [cited 2022 September 2];31(6). Available from: /pmc/articles/PMC8646520/
• 31. Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. 2021 [cited 2022 Sep 2];27(4):626–31. Available from: https://pubmed.ncbi.nlm.nih.gov/33692530/
• 32. Latz CA, Decarlo C, Boitano L, Png CYMM, Patell R, Conrad MF, et al. Blood type and outcomes in patients with COVID-19. 2020 September 1 [cited 2021 December 13];99(9). Available from: /pmc/articles/PMC7354354/
• 33. Kozak R, Armstrong SM, Salvant E, Ritzker C, Feld J, Biondi MJ, et al. Recognition of long-covid-19 patients in a canadian tertiary hospital setting: A retrospective analysis of their clinical and laboratory characteristics. Pathogens [Internet]. 2021 October 1 [cited 2022 September 2];10(10). Available from: /pmc/articles/PMC8537802/
• 34. Fouladseresht H, Ghamar Talepoor A, Eskandari N, Norouzian M, Ghezelbash B, Beyranvand MR, et al. Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities. 2022 January 20 [cited 2022 September 2];12:5788. Available from: https://pubmed.ncbi.nlm.nih.gov/35126355/
• 35. Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br J Haematol [Internet]. 2020 Jul 1 [cited 2022 Feb 25];190(1):24–7. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.16797
• 36. Barnkob MB, Pottegård A, Støvring H, Haunstrup TM, Homburg K, Larsen R, et al. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. 2020 Oct [cited 2022 February 25];4(20):4990–3. Available from: https://pubmed.ncbi.nlm.nih.gov/33057631/